Po‐Heng Chuang

601 citations
33 papers · 433 indexed · h-index 13
Topics
Liver Disease Diagnosis and Treatment (22 papers)Hepatitis C virus research (20 papers)Hepatitis B Virus Studies (18 papers)
Partner nations
TaiwanChinaUnited States

In The Last Decade

Po‐Heng Chuang

32 papers receiving 430 citations

Peers

Po‐Heng Chuang
Comparison fields: 5 of 65
  • Epidemiology 301
  • Hepatology 289
  • Oncology 51
  • Molecular Biology 36
  • Cancer Research 33
Replace Tamami Abe with:
Tamami Abe Japan
Shumei Lin China
Thông Dao France
Ken Nishino Japan
Zhandong Li China
Yuta Wakui Japan
Shin Fujioka Japan
Yao‐Li Cui China
Hannah M. Lee United States
B.E. Annicchiarico Italy
Po‐Heng Chuang relative to Tamami Abe Japan Tamami Abe's profile →
Citations per field
00.5×8.5×
Tamami Abe · 1×
Citations per year

Countries citing papers authored by Po‐Heng Chuang

Since Specialization
Citations

This map shows the geographic impact of Po‐Heng Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Heng Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Heng Chuang more than expected).

Fields of papers citing papers by Po‐Heng Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Heng Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Heng Chuang. The network helps show where Po‐Heng Chuang may publish in the future.

Co-authorship network of co-authors of Po‐Heng Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Heng Chuang. A scholar is included among the top collaborators of Po‐Heng Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Heng Chuang. Po‐Heng Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2
Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy.
2
3 4
4 0
5 2
6 19
7 9
8 7
9 12
10 20
11 45
12 20
13 22
14 11
15 17
16 8
17 13
18 44
19 25
20 1

About Po‐Heng Chuang

Po‐Heng Chuang is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 33 papers that have together received 433 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (20 papers) and Hepatitis B Virus Studies (18 papers). The work is most often cited by research in Hepatology (289 citations), Epidemiology (301 citations) and Cancer Research (33 citations). Po‐Heng Chuang has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Hsueh‐Chou Lai, Cheng‐Yuan Peng, Wen‐Pang Su, Sheng‐Hung Chen, Yufen Li, Wen-Pang Su, Hung‐Wei Wang, I‐Ping Chiang, Chia‐Hsin Lin and Wei‐Fan Hsu. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026